Series date: 
01/01/2023 - 12:00am CST to 12/31/2023 - 11:59pm CST

Course Director:
Diana Bottari, DO

Overview:
MEDtalks is a monthly live streaming webinar series where we feature clinicians from across Advocate Aurora Health who share perspectives on the latest clinical practice, changing studies and provide local relevance for healthcare professionals
  
Overall Objectives:

Update treatment plans based on evidence-based practices and apply in clinical practice when caring for patients seen in practice of primary care medicine.

Target Audience:  This activity is designed for physicians, advanced practice clinicians and other interested healthcare professionals
 

Accreditation Statement
In support of improving patient care, Advocate Aurora Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Statement(s)

American Medical Association (AMA) 
Advocate Aurora Health designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Board Recognition Statement(s)

American Board of Surgery (ABS)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.   

Contact Information:

These programs may be recorded and posted online for ongoing viewing. Please turn your camera/video off if you do not want your image shared within the recorded video. If you have any concerns, please contact the CME Office at cme@aah.org.

Series location: 
Virtual via Microsoft Teams
United States

Comments

hello

Christopher Molitor replied on